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Effects of one dose of a 30 cH potency of Thyroidinum on weight reduction in 
fasting patients 
Schmidt JM, Ostermayr B. 
D o e s a h o m e o p a t h i c u l t r a m o l e c u l a r d i l u t i o n o f T h y r o i d i n u m 3 0 c H af fec t t h e rate of b o d y w e i g h t 
r e d u c t i o n i n f a s t i n g p a t i e n t s ? A r a n d o m i s e d p l a c e b o - c o n t r o l l e d d o u b l e - b l i n d c l i n i c a l t r i a l . 
Homeopathy 2 0 0 2 ; 9 1 : 1 9 7 - 2 0 6 . 
Aim 
T h e a i m o f t h e i n v e s t i g a t o r s was t o m e a s u r e t h e ef fects 
o f a h o m o e o p a t h i c u l t r a m o l e c u l a r d i l u t i o n u n d e r s t a n d -
a r d i s e d c o n d i t i o n s i n a c l i n i c a l m o d e l . 
Design 
R a n d o m i s e d , p l a c e b o - c o n t r o l l e d , d o u b l e - b l i n d , p a r a l l e l 
g r o u p , m o n o c e n t r e s t u d y . 
Setting 
H o s p i t a l f o r n a t u r o p a t h y i n M u n i c h , G e r m a n y ; a h o s p i -
t a l w i t h a t r a d i t i o n o f h o m o e o p a t h i c t r e a t m e n t s . 
Part ic ipants 
Fas t ing p a t i e n t s t h a t e x p e r i e n c e d a S t a g n a t i o n o f r e d u c -
t i o n o f b o d y - w e i g h t af ter a w e i g h t r e d u c t i o n o f at least 
lOOg/day i n t h e p r e c e d i n g days . A t o t a l o f 2 0 8 p a t i e n t s 
p a r t i c i p a t e d , 102 r e c e i v e d T h y r o i d i n u m a n d 106 p l a c e b o . 
Intervent ion 
O n e dose o f f i v e p e l l e t s o f e i t h e r T h y r o i d i n u m C 3 0 o r 
p l a c e b o . 
Main outcome measures 
P r i m a r y o u t c o m e m e a s u r e was w e i g h t r e d u c t i o n o n t h e 
s e c o n d d a y a f t e r m e d i c a t i o n . S e c o n d a r y o u t c o m e 
measures w e r e w e i g h t r e d u c t i o n o n t h e f i r s t a n d t h i r d 
d a y a f ter m e d i c a t i o n , c o m p l a i n t s a n d l a b o r a t o r y 
f i n d i n g s . 
Main results 
P a t i e n t s t h a t r e c e i v e d T h y r o i d i n u m h a d less w e i g h t 
r e d u c t i o n o n t h e s e c o n d d a y a f ter m e d i c a t i o n t h a n 
p a t i e n t s t h a t r e c e i v e d p l a c e b o , t h e m e a n d i f f e r e n c e w a s 
9 2 g [ 9 5 % c o n f i d e n c e i n t e r v a l ( C I ) 7 - 1 7 6 ] . A d j u s t m e n t 
f o r b a s e l i n e average w e i g h t r e d u c t i o n w e a k e n e d t h e 
a s s o c i a t i o n . 
Authors ' conclusions 
' P a t i e n t s r e c e i v i n g T h y r o i d i n u m 3 0 C h a d less w e i g h t 
r e d u c t i o n o n t h e s e c o n d d a y a f t e r t r e a t m e n t t h a n 
p a t i e n t s r e c e i v i n g p l a c e b o . H o w e v e r , t h e resul ts m u s t 
be i n t e r p r e t e d w i t h c a u t i o n because t h e r e w e r e n o s ig-
n i f i c a n t d i f f e r e n c e s i n o t h e r o u t c o m e measures a n d 
a d j u s t m e n t f o r b a s e l i n e d i f f e r e n c e s r e n d e r e d t h e d i f f e r -
ence f o r t h e m a i n o u t c o m e m e a s u r e n o n - s i g n i f i c a n t . ' 
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S a n a t o r i u m s p l a t z 2, D - 8 1 5 4 5 M u n i c h , G e r m a n y . 
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Authors' reply 
Because of the lack of Space, w e c a n on ly reply to 
the ob ject ions . 
In format ion on p r imary d iagnoses of the pa r t ic ipat ing 
patients can be found on p. 198 of our paper , where it reads: 
'Fasting therapy is applied to a b r o a d spectrum of diagnoses 
inc luding hypertension, diabetes, Osteoarthritis, bronchial 
asthmo, migra ine, etc . ' Furthermore, detai led Information on 
diagnoses as wel l as on a g e , height, we ight , peculiar Symp-
toms, etc. of each single patient is g iven in the füll p u b l i c a t i o n . 1 
Yes, w e treated 31 men with p l a c e b o a n d 2 6 men wi th 
Thyro id inum. Randomisat ion was stratif ied for males a n d 
females, in blocks of six. A g a i n , an exact descr ipt ion had 
a l ready been given in our G e r m a n pub l icat ion , on p. 2 7 . To 
summarise: there were t w o sets of Containers, one for male a n d 
one for female patients. W e used M 0 0 1 - M 0 5 7 a n d F 0 0 1 -
F154 . O n p. 2 0 0 of our paper , w e wro te : ' 21 1 patients 
we re e l ig ib le a n d a l located a randomisat ion number. Three 
patients (two Thyro id inum, one p lacebo) w i t h d r e w consent 
before open ing the Container. Thus, 2 0 8 patients actually 
received study m e d i c a t i o n . ' So, three Containers w e r e random-
ised but not used. Two of them w e r e p rov ided for females, one 
for a man ( M 0 4 5 , conta in ing Thyroidinum). In a d d i t i o n , just 
once dur ing the trai l , one of the physicians on duty, by mistake, 
g a v e the study medicat ion out of a Container f rom the set 
p rov ided for female patients (Fl 16, conta in ing p lacebo) to a 
male patient. O f course, in the analysis this medicat ion was 
counted for a male patient. Hence, to reconstruct the or ig ina l 
randomisat ion numbers of males it is necessary to a d d one 
Thyroid inum male ( M 0 4 5 ) a n d to subtract o n e p lacebo male 
(Fl 16), resulting in 2 7 T h y r o i d i n u m a n d 3 0 p l a c e b o males. A 
di f ference of three men is compat ib le wi th stratif ied randomisa-
t ion in blocks of 6: M 0 5 5 - M 0 5 7 were p l a c e b o . 
Instead of per fo rming an exp lo rato ry study befo re , w e 
des igned a n d c o n d u c t e d a two-step tr ial a c c o r d i n g to the 
sequent ial p l a n , w i th an inter im analys is after 5 0 patients. 
A s ign i f icant result (as wel l as a devastat ing one) w o u l d have 
led to terminat ion of the study in an ear ly s tage. Unl ike these 
extremes, the inter im analys is s h o w e d a very p romis ing , yet 
still not s ign i f icant result (p. 3 0 in G e r m a n pub l icat ion) . For 
that reason w e feit e n c o u r a g e d to cont inue the tr ial under the 
same condi t ions , up to 2 0 8 patients. C o m p a r e d w i th the 
inter im analys is , however , the d i f ference in w e i g h t reduct ion 
between groups on the second d a y after t reatment d w i n d l e d 
f rom 1 8 1 g to 9 2 g , whereas the basel ine di f ferences 
increased. These unexpected f indings w e a k e n e d the 
otherwise s ign i f icant result to a non-s igni f icant level 
( P = 0 . 0 9 ) . 
JM Schmidt, M u n i c h , G e r m a n y 
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